Paul Tudor Jones Aquestive Therapeutics, Inc. Transaction History
Tudor Investment Corp Et Al
- $25.1 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding AQST
# of Institutions
122Shares Held
46.9MCall Options Held
174KPut Options Held
143K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$32.6 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$18.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.35MShares$14.4 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY2.63MShares$8.73 Million1.54% of portfolio
-
Franklin Resources Inc San Mateo, CA2.13MShares$7.09 Million0.0% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $177M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...